890
Views
0
CrossRef citations to date
0
Altmetric
Short Communication

A UK cost–effectiveness analysis of trifluridine/tipiracil for heavily pretreated metastatic gastroesophageal cancers

, , , ORCID Icon, , ORCID Icon & ORCID Icon show all
Pages 643-650 | Received 29 Jun 2022, Accepted 02 Mar 2022, Published online: 28 Apr 2023